# Pfizer PAP India — Powered by TATA 1MG > Patient Access Program for oncology drugs offering subsidies and drug assistance. (iPhone/iPad app by TATA 1mg Healthcare Solutions Pvt Ltd.) - Source: https://appshunter.io/ios/app/pfizer-pap-india/id6444154340 (this page in markdown: same URL + `.md`) - Developer: [TATA 1mg Healthcare Solutions Pvt Ltd](https://appshunter.io/developer/1082630750) - Category: Medical, Health & Fitness - Price: Free - Rating: 4.50/5 from 4 App Store ratings - Age rating: 12+ - Requires: iOS 17.5 · 1 MB - Languages: American English - Released: 2022-11-15 - Data updated: 2026-08-15 - Monetization: free - User reviews in markdown: https://appshunter.io/ios/app/pfizer-pap-india/id6444154340/reviews.md ## What is Pfizer PAP India? Patient Access Program (PAP), being implemented by MediAngels (Tata 1mg Technologies Pvt. Ltd.), and supported by Pfizer India Limited is a PAN India Program for Oncology drugs providing better access and facilitating either a partial or full subsidy on these drugs. Currently there are 8 different PAPs available for oncology drugs (Dacoplice, Lorbriqua, Inonza, Palbace, Crizalk, Sutent, Inlyta, Aromasin and Campto). Each of these PAPs have various schemes available and depending upon the eligibility (as defined based on the indication for specific drugs) within the Program, patients may enroll themselves and avail the benefits of partial / full subsidy. Patients are prescribed these drugs by HealthCare Practitioners (HCPs) based on their medical conditions and post that patients may choose to enroll into the PAP. Once the patients consent to enroll, the MediAngels team facilitates the enrollment process by requesting for basic information & documents including photo ID proof, address proof and prescription. Enrollment into the Program is governed by patient’s eligibility as per the indication(s) defined for the specific drug. Upon successful completion of enrollment, patients may select PAP scheme from the available options and submit invoices (paid purchase proofs) along with valid prescriptions to avail free drug assistance. ## Key features - Oncology drug access program - Partial or full drug subsidies - Enrollment in various PAP schemes - Facilitates drug assistance - Requires eligibility verification - Digital document submission ## Frequently asked questions about Pfizer PAP India ### What is Pfizer PAP India? Pfizer PAP India is a Patient Access Program that provides better access to oncology drugs by facilitating partial or full subsidies. It is implemented by MediAngels and supported by Pfizer India Limited. ### What oncology drugs are covered by Pfizer PAP India? Currently, Pfizer PAP India covers 8 different PAPs for oncology drugs including Dacoplice, Lorbriqua, Inonza, Palbace, Crizalk, Sutent, Inlyta, Aromasin, and Campto. ### How can patients enroll in Pfizer PAP India? Patients prescribed eligible oncology drugs by a Healthcare Practitioner can choose to enroll. The MediAngels team facilitates enrollment by requesting basic information and documents like photo ID, address proof, and prescription. ### What is required for patients to avail drug assistance through Pfizer PAP India? After successful enrollment and selection of a PAP scheme, patients need to submit paid purchase proofs (invoices) along with valid prescriptions to avail free drug assistance. ### What is the eligibility criteria for Pfizer PAP India? Enrollment into the program is governed by patient eligibility as defined by the indication for the specific drug. Patients must meet these criteria to be considered for the subsidy. ### Does Pfizer PAP India have ads? No, Pfizer PAP India does not contain advertisements. The app is free to use and does not display any ads. ### What devices does Pfizer PAP India support? Pfizer PAP India is currently supported on iPhones. Compatibility with other devices may be available in future updates. ### How often is Pfizer PAP India updated? The latest version of Pfizer PAP India is 3.1.0, which was last updated on December 13, 2025. Updates are provided to improve functionality and add new features. ## Version history (last 5 releases) ### 3.1.0 — 2025-12-13 To make our app better for you, we frequently update it. This release includes: - Bug Fixes and Improvements ### 3.0.0 — 2025-12-12 To make our app better for you, we frequently update it. This release includes: - Bug Fixes and Improvements ### 2.2.0 — 2025-12-04 To make our app better for you, we frequently update it. This release includes: - Bug Fixes and Improvements ### 2.1.0 — 2025-12-01 To make our app better for you, we frequently update it. This release includes: - Bug Fixes and Improvements ### 2.0.0 — 2025-11-08 To make our app better for you, we frequently update it. This release includes: • Physical Verification booking and status tracking • eKYC initiation and status updates • FOC order requests and reminders • General bug fixes and performance improvements ## More apps by TATA 1mg Healthcare Solutions Pvt Ltd - [Tata 1mg - Healthcare App](https://appshunter.io/ios/app/tata-1mg-healthcare-app/id554578419) - [Tata 1mg for Doctors](https://appshunter.io/ios/app/tata-1mg-for-doctors/id1113929857) - [OPD Powered by 1mg!](https://appshunter.io/ios/app/opd-powered-by-1mg/id1507687380) All apps by TATA 1mg Healthcare Solutions Pvt Ltd: https://appshunter.io/developer/1082630750 --- *Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-08-15.*